胆盐代谢及转运和肝内胆汁淤积分子医学和临床的相互促-医学资料

上传人:杰猫 文档编号:119468073 上传时间:2020-01-16 格式:PPT 页数:37 大小:579.51KB
返回 下载 相关 举报
胆盐代谢及转运和肝内胆汁淤积分子医学和临床的相互促-医学资料_第1页
第1页 / 共37页
胆盐代谢及转运和肝内胆汁淤积分子医学和临床的相互促-医学资料_第2页
第2页 / 共37页
胆盐代谢及转运和肝内胆汁淤积分子医学和临床的相互促-医学资料_第3页
第3页 / 共37页
胆盐代谢及转运和肝内胆汁淤积分子医学和临床的相互促-医学资料_第4页
第4页 / 共37页
胆盐代谢及转运和肝内胆汁淤积分子医学和临床的相互促-医学资料_第5页
第5页 / 共37页
点击查看更多>>
资源描述

《胆盐代谢及转运和肝内胆汁淤积分子医学和临床的相互促-医学资料》由会员分享,可在线阅读,更多相关《胆盐代谢及转运和肝内胆汁淤积分子医学和临床的相互促-医学资料(37页珍藏版)》请在金锄头文库上搜索。

1、胆盐代谢及转运和肝内胆汁淤积 分子医学和临床的相互促进 王建设 复旦大学附属儿科医院 复旦大学儿童肝病中心 “特发性”新生儿肝炎 GGT and the outcome July 1, 1981-Jan 1, 1985, 186 infants, 29 diagnosed as INHS, followed up for at least 1 year, or until death: 17 with increased GGT (=2.1*normal upper limit), All but 1 in good prognosis 12 with normal GGT, All poor

2、 prognosis Maggiore G, et al. J Pediatr, 1987;112:251-252. Kings病例入选标准 Aug 1991 to Nov 2000, Conjugated hyperbilirubinemia under 3 months of age (973 cases) No specific etiologic factor can be ascertained after comprehensive work- up Followed up for at least one year or until died Wang JS, Eur J Ped

3、iatr, 2006, in press 病例排除标准 INR1.2 and not be fully corrected after vitamin K injection Follow up interval longer than 3 months Other severe congenital abnormalities G6PD deficiency Evidence of active CMV infection in spite of no inclusion found on liver biopsy USS demonstrated bile duct dilation. B

4、asic information 128 cases elected, 110 biopsyed 6 patients diagnosed as PFIC 1 or 2, 1 recurred jaundice. GGT level with endpoints without endpoints Presentation 29-84 52.9%100U/L组28例,2例预后不良(P=0.002) 血清GGT水平和预后的有关(和CMV状态无关 ) 王中林. 肝脏 2005,(4) 进行性家族性肝内郁胆(PFIC ) First reported in Amish family (Byler d

5、isease), autosomal recessive inheritance Clinical presentation: Cholestasis and low GGT Pruritus, Epistaxis Normal or near normal cholesterol, No xanthomas FIC1 deficiency BRIC 基因定位18q21-22 Houwen RH, 1994, Nat Genet 8:380 PFIC (Byler disease)基因定位18q21-22 Carlton VE, 1995, 4:1049-1053 PFIC遗传异质性,PFIC

6、1 ATP8B1基因,编码的产物FIC1 Bull LN, Nat Genet 1998, 18:219 FIC1 deficiency (续) Greenland familial cholestasis, Asp554Asn Klomp LW, Hepatology, 2000,32:1337 各地的散发性病例 无家族史、父母非近亲婚配 欧洲、日本、中国台湾 新认识 PFIC1和BRIC 1有同一基因引起 PFIC多见缺失、移位、无义突变 BRIC多见错义突变 PFIC1和BRIC 1可表现为一连续过程 共同的临床特征 Low GGT in cholestasis Low GGT expr

7、ession Defect of bile salt exportation BSEP deficiency 1997年,低GGT PFIC的第二个基因(沙特) 被定位于2q24,因此这种被命名为PFIC2 Strautnieks SS. Am J Hum Genet. 61,630. 1998年, BSEP基因突变引起PFIC 2 Strautnieks SS. Nat Genet. 20,233. 2004 年,BRIC 2由ABCB11突变 PFIC多见缺失、移位、无义突变, BRIC多见错义突变 van Mil SWC, Gastroenterology, 127,379. PFIC

8、2 见于欧洲、日本、 中国等世界各地 Case 2 20061388 GA, A167I Case 3 CAG TAG Exon 18 C2230T Q702Stop Case 5 Intron 22 (+3) Exon 7 T A 562 GT G188W Case 5 Intron 22 (+3) 紧邻剪切位点(ACCT) T to A Hum AAGATTACCTG Mus AAGATTACCTG Dog AAGATTACCTG Cow TAGATTACCTG Case AAGATAACCTG Case 7 Intron 6 T+63T/G (167) Low GGT in choles

9、tasis Defect of bile salt exportation Defect of bile salt synthesis Bile acid synthetic defect 16 enzymes catalyze 17 reactions in bile acid synthesis from cholesterol Russell DW. Annu Rev Biochem 2003,72,137 Defects in different enzymes associate with neonatal cholestasis Delta(4)-3-oxosteroid 5bet

10、a-reductase(AKR1D1) Gonzales E, J Hepatol 2004,40,716 Oxysterol 7-hydroxylase (CRP7B1) Setchell KDR, J Clin Invest 1998,102,1690 Bile acid synthetic defect -PFIC 4 2000, HSD3B7, chromosome 16p12-p11.2 Encoding 3-beta-hydroxy-delta-5-C27 steroid oxidoreductase (C27-3-BETA-HSD) Participate in all path

11、ways of bile acid synthesis (7- alpha-hydroxylated sterols) 2 bp deletion in a Saudi boy with neonatal PIC Schwarz M. J Clin Invest 2000,106,1175 2003, confirmed in a Chilean family, a French family, a British and a Canadian family Cheng JB. J Clin Endocr Metab 2003, 88:1833 对临床的意义 将PFIC和BRIC区分出不同的类

12、型 Diarrhea, Pancreatitis (PFIC1) 胆石症 (PFIC2) 将PFIC和BRIC有机的联系在一起 疾病的两极,表型可转换 van Ooteghem NA, J Hepatol 2002,36,439 预后判断 More progressive in BSEP Malignancy in BSEP Growth retardation in FIC1 对临床的意义 Histology PFIC1:Cholestasis with nonspecific hepatitis, Low expression of GGT at canalicular PFIC2:Neo

13、natal hepatitis (multinuclear giant cell transformation) Bile acid synthetic defect: Giant cell hepatitis Chen HL, J Pediatr. 2002,140,119 Knisely AS. Perspect Pediatr Pathol 2000,3,113 Bove KE. Pediatr Dev Pathol 2004,7,315 对临床的意义 Treatment Exogenous bile acid administration Cure for some bile acid

14、 synthetic defect Transplatation cure the disease in BSEP Outside liver symptoms continue(FIC1) Partial bile diversion D482G or E297G respond well in BSEP “Transit”neonatal hepatitis The remaining 103 infants were included for analysis. Median age at presentation was 40 days (range 7 - 87 days) Foll

15、ow up period ranged between 315 days to 9.6 years, with a median of 873 days There were no patient deaths 根据入 院时 GGT分 组,组 织学表 现有区 别 Wang JS, Eur J Pediatr, 2006, in press GGT levels rise as bilirubin & AST levels fall. There is a wide variation in time intervals to peak and resolution of disease. This patient presented on day 10 and disease resolved by day 151. Typical biochemistry dyn

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 医学/心理学 > 基础医学

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号